Gabriel Cohn

Gabriel Cohn

Geen lopende functies

65 jaar
Health Technology
Consumer Services
Health Services

Profiel

Gabriel M.
Cohn
worked as the Medical Director & Head-Clinical Division at Baystate Medical Center from 1993 to 2008.
He also worked as the Director-Reproductive Genetics at State University of New York at Downstate Medical Center in 1992.
Later, he worked as the Senior Medical Director-Clinical Sciences at Shire Human Genetic Therapies, Inc. and as the VP, Head-Global Clinical & Medical Affairs at OvaScience, Inc. from 2015 to 2017.
He served as the Chief Medical Officer at Homology Medicines, Inc. and as the Vice President-Clinical Development at Avrobio, Inc. from 2017 to 2019.
Dr. Cohn completed his undergraduate degree from Brooklyn College in 1980, his doctorate from SUNY Upstate Medical University in 1986, and his MBA from the University of Massachusetts in 2006.

Eerdere bekende functies van Gabriel Cohn

BedrijvenFunctieEinde
AVROBIO, INC. Hoofd Techniek/Wetenschap/O&O 01-12-2019
Hoofd Techniek/Wetenschap/O&O 01-07-2017
Hoofd Techniek/Wetenschap/O&O 01-01-2008
State University of New York at Downstate Medical Center Corporate Officer/Principal 01-09-1993
Corporate Officer/Principal -
Ervaring van Gabriel Cohn in detail bekijken

Opleiding van Gabriel Cohn

SUNY Upstate Medical University Doctorate Degree
Brooklyn College Undergraduate Degree
University of Massachusetts Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Gabriel Cohn in detail bekijken

Connecties

100 +

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
AVROBIO, INC.

Health Technology

Bedrijven in privébezit4

Health Technology

Health Technology

Health Services

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Gabriel Cohn
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU